Document is current
Any future updates will be listed below
-
Authors
De Corte, Thomas https://orcid.org/0000-0001-5011-6640
Verhaeghe, Jarne https://orcid.org/0000-0002-3322-150X
Dhaese, Sofie https://orcid.org/0000-0002-2252-7167
Van Vooren, Sarah https://orcid.org/0000-0001-7278-1895
Boelens, Jerina https://orcid.org/0000-0003-2282-8194
G. Verstraete, Alain https://orcid.org/0000-0002-0956-3315
Stove, Veronique https://orcid.org/0000-0002-2447-971X
Ongenae, Femke https://orcid.org/0000-0003-2529-5477
De Bus, Liesbet https://orcid.org/0000-0003-1456-5857
Depuydt, Pieter https://orcid.org/0000-0001-5164-5376
Van Hoecke, Sofie https://orcid.org/0000-0002-7865-6793
J. De Waele, Jan https://orcid.org/0000-0003-1017-9748
-
Funding
Funding for this research was provided by:
Fonds Wetenschappelijk Onderzoek (G085920N)
Fonds Wetenschappelijk Onderzoek (1S59522N)
Fonds Wetenschappelijk Onderzoek (1881020N)
- License Information
-
More Information
This article is maintained by: Elsevier
Article Title: Pathogen-based target attainment of optimized continuous infusion dosing regimens of piperacillin-tazobactam and meropenem in surgical ICU patients: a prospective single center observational study
Journal Title: Annals of Intensive Care
CrossRef DOI link to publisher maintained version: https://doi.org/10.1186/s13613-023-01129-6
Content Type: article
Copyright: Copyright © 2023 The Author(s) 2023. Published by Elsevier Masson SAS
